Quarterly report pursuant to Section 13 or 15(d)

Schedule of segment information (Details)

v3.22.1
Schedule of segment information (Details) - USD ($)
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Dec. 31, 2021
Segment Reporting Information [Line Items]      
Net sales $ 1,848,898 $ 1,320,624  
Operating income (loss) 31,376 (164,743)  
Interest income 14,353 16,489  
Interest expense 18,207 12,070  
Property Additions 27,902 7,859  
Fixed asset depreciation and amortization 15,890 9,421  
Total asset 4,836,918 4,775,305 $ 4,786,441
Cannabis and Medical Marijuana Segment [Member]      
Segment Reporting Information [Line Items]      
Net sales 9,017 10,871  
Operating income (loss) 5,491 6,125  
Interest income  
Interest expense  
Property Additions  
Fixed asset depreciation and amortization  
Total asset 879,789 1,005,990  
Facility Operations Related [Member]      
Segment Reporting Information [Line Items]      
Net sales 1,839,881 1,309,753  
Operating income (loss) 187,150 (3,946)  
Interest income  
Interest expense 10,386 8,498  
Property Additions 27,902 6,595  
Fixed asset depreciation and amortization 15,368 7,960  
Total asset 2,411,343 2,124,769  
Corporate and Eliminations [Member]      
Segment Reporting Information [Line Items]      
Net sales  
Operating income (loss) (161,265) (166,922)  
Interest income 14,353 16,489  
Interest expense 7,821 3,572  
Property Additions 1,264  
Fixed asset depreciation and amortization 522 1,461  
Total asset $ 1,545,786 $ 1,644,546